HSDT vs. QTI, STRR, GIA, NXL, NUWE, TIVC, NDRA, VRAYQ, VIVE, and IRIX
Should you be buying Helius Medical Technologies stock or one of its competitors? The main competitors of Helius Medical Technologies include QT Imaging (QTI), Star Equity (STRR), GigCapital5 (GIA), Nexalin Technology (NXL), Nuwellis (NUWE), Tivic Health Systems (TIVC), ENDRA Life Sciences (NDRA), ViewRay (VRAYQ), Viveve Medical (VIVE), and IRIDEX (IRIX). These companies are all part of the "electromedical equipment" industry.
Helius Medical Technologies (NASDAQ:HSDT) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, community ranking, analyst recommendations and profitability.
18.6% of Helius Medical Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 5.1% of Helius Medical Technologies shares are held by company insiders. Comparatively, 75.4% of QT Imaging shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, Helius Medical Technologies and Helius Medical Technologies both had 1 articles in the media. QT Imaging's average media sentiment score of 1.15 beat Helius Medical Technologies' score of 0.00 indicating that QT Imaging is being referred to more favorably in the news media.
QT Imaging has higher revenue and earnings than Helius Medical Technologies.
Helius Medical Technologies currently has a consensus target price of $24.00, indicating a potential upside of 2,014.54%. Given Helius Medical Technologies' higher probable upside, research analysts clearly believe Helius Medical Technologies is more favorable than QT Imaging.
QT Imaging has a net margin of 0.00% compared to Helius Medical Technologies' net margin of -1,328.14%. QT Imaging's return on equity of 0.00% beat Helius Medical Technologies' return on equity.
Helius Medical Technologies has a beta of 1.58, meaning that its share price is 58% more volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500.
Helius Medical Technologies received 20 more outperform votes than QT Imaging when rated by MarketBeat users.
Summary
QT Imaging beats Helius Medical Technologies on 9 of the 13 factors compared between the two stocks.
Get Helius Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for HSDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HSDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Helius Medical Technologies Competitors List
Related Companies and Tools
